Correlation Between Microsoft and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Microsoft and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Moleculin Biotech, you can compare the effects of market volatilities on Microsoft and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Moleculin Biotech.
Diversification Opportunities for Microsoft and Moleculin Biotech
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Microsoft and Moleculin is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Microsoft i.e., Microsoft and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Microsoft and Moleculin Biotech
Given the investment horizon of 90 days Microsoft is expected to generate 5.69 times less return on investment than Moleculin Biotech. But when comparing it to its historical volatility, Microsoft is 4.01 times less risky than Moleculin Biotech. It trades about 0.02 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 262.00 in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Moleculin Biotech
Performance |
| Timeline |
| Microsoft |
| Moleculin Biotech |
Microsoft and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Moleculin Biotech
The main advantage of trading using opposite Microsoft and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Microsoft vs. GigaCloud Technology Class | Microsoft vs. Arqit Quantum | Microsoft vs. Cemtrex | Microsoft vs. Paysafe |
| Moleculin Biotech vs. Eliem Therapeutics | Moleculin Biotech vs. Scpharmaceuticals | Moleculin Biotech vs. Milestone Pharmaceuticals | Moleculin Biotech vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |